ADA Scientific Sessions 2025 Abstract

Cardiovascular Events in Patients Treated with Sulfonylureas—A Target Trial Emulation

By Alexander Turchin, Lucia C. Petito, Emma Hegermiller, Miguel Ángel Hernán

Study in peopleInterventions

The paper

Alexander Turchin, Lucia C. Petito, Emma Hegermiller, Miguel Ángel Hernán

Boston

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, oral 295-OR

doi.org/10.2337/db25-295-or

Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Pharmacology and Therapeutics4 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk